Cancer: Difference between revisions

From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs)
No edit summary
David Canner (talk | contribs)
No edit summary
Line 65: Line 65:
<br />
<br />


====FDA Approved Treatments for [[Cancer]]====
To View FDA Approved Treatments for [[Cancer]] See: [[Pharmaceutical_Drugs#Treatments|Treatments]]
<table style="background: cellspacing="5px"  cellpadding="10px" width="100%">
<tr>
<td style="width:25%; vertical-align:top;border-width:1px; border-style:inset">
=====[[EGFR]] Inhibitor=====
* Herceptin - Generic: Trastuzumab
* [[Iressa]] - Generic: Gefitinib
* [[Tarceva]] - Generic: Erlotinib
=====[[VEGF]] Inhibitor=====
* Avastin - Generic: Bevacizumab
* Tykerb - Generic: Lapatinib
* Sutent - Generic: Sunitinib
* Nexavar - Generic: Sorafenib
</td>
</tr>
</table>


To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]]
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]]
__NOEDITSECTION__

Revision as of 09:31, 30 November 2010

The Progression of Cancer

Cancer is a class of diseases marked by uncontrolled cellular growth resulting in intrusion on and destruction of adjacent tissues, while often spreading to other locations in the body via the lymphatic or circulatory systems.


To view Cancer related proteins which are Structure Index entries see:


To view automatically seeded indices concerning Cancer See:


To View FDA Approved Treatments for Cancer See: Treatments

To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets